Trials / Conditions / Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity

Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity

13 registered clinical trials studyying Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoi NCT02123511	Mayo Clinic	Phase 2
Withdrawn	Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropha NCT01718223	Roswell Park Cancer Institute	N/A
Terminated	Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC NCT01283178	Virginia Commonwealth University	Phase 1
Terminated	Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer NCT01254734	City of Hope Medical Center	N/A
Terminated	Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radi NCT01164566	Wake Forest University Health Sciences	N/A
Completed	L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For NCT01155609	University of Washington	N/A
Recruiting	Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck NCT01473784	Ohio State University Comprehensive Cancer Center	N/A
Completed	Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. NCT01469429	Ohio State University Comprehensive Cancer Center	Phase 1 / Phase 2
Completed	Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral NCT01504932	Ohio State University Comprehensive Cancer Center	N/A
Completed	Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck NCT00470496	Roswell Park Cancer Institute	Phase 1
Completed	Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer NCT00049166	National Cancer Institute (NCI)	Phase 1
Terminated	EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer NCT00896961	National Cancer Institute (NCI)	N/A
Withdrawn	Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity NCT02119728	Roswell Park Cancer Institute	Phase 2